Gepato-gastroeterologik tadqiqotlar jurnali 2022, №2

Subject of the article

РЕЦИДИВИРУЮЩИЕ РЕСПИРАТОРНЫЕ ИНФЕКЦИИ У ДЕТЕЙ КАК ПРЕДВЕСТНИК ПЕРВИЧНЫХ ИММУНОДЕФИЦИТОВ (Обзорная статья) (17-20)

Authors

Ахмедова Д. Ю.; Эшкобилов Ф. Р.

Institution

Самаркандский государственный медицинский университет

Abstract

Инфекции дыхательных путей у детей являются одной из наиболее частых причин обращения к врачу и госпитализации и связаны со значительной заболеваемостью и смертностью. Респираторные инфекции являются распространенными и частыми заболеваниями и представляют собой одну из основных жалоб у детей и подростков. Роль врачей и других медицинских работников расширилась от простого лечения болезней до реализации мер, направленных на поддержание здоровья и профилактику заболеваний. Назначение и применение каждого иммуномодулирующего средства должно осуществляться корректно только в указанных случаях с индивидуальным подходом к каждому ребенку с учетом всех правил.

Key words

рецидивирующие респираторные инфекции, первичный иммунодефицит, гастроэзофагеальный рефлюкс, кистозный фиброз.

Literature

1. Douros K, Everard ML. Time to say goodbye to bronchiolitis, viral wheeze, reactive airways disease, wheeze bronchitis and all that. Front. Pediatr. (2020) 8:218. doi: 10.3389/fped.2020.00218 2. Camargo CA. Chapter 112 - vitamin D, acute respiratory infection, and asthma/chronic obstructive pulmonary disease. In: Feldman D, editor. Vitamin D (Fourth Edition) London: Academic Press (2018) p. 1095–120. 3. Report GM. Global Strategy Forasthma Management and Prevention Updated 2020. (2018) Available online at: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. (accessed May 14, 2020). 4. Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev EndocrMetabDisord. (2017) 18:153–65. doi: 10.1007/s11154-017-9424-1 5. Jolliffe DA, Greiller CL, Mein CA, Hoti M, Bakhsoliani E, Telcian AG, et al. Vitamin D receptor genotype influences risk of upper respiratory infection. Br J Nutr. (2018) 120:891–900. doi: 10.1017/S000711451800209X 6. Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. (2017) 27:e1909. doi: 10.1002/rmv.1909 7. Newton AH, Cardani A, Braciale TJ. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. Semin Immunopathol. (2016) 38:471–82. doi: 10.1007/s00281-016-0558-0 8. Bozzetto S, Carraro S, Giordano G, Boner A, Baraldi E. Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy. (2012) 67:10–7. doi: 10.1111/j.1398-9995.2011.02711.x 9. Carlberg C. Vitamin D genomics: from in vitro to in vivo. Front Endocrinol. (2018) 9:250. doi: 10.3389/fendo.2018.00250 10. Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. (2015) 7:4240–70. doi: 10.3390/nu7064240 11. Douros K, Boutopoulou B, Fouzas S, Loukou I. Asthma and allergy “epidemic” and the role of vitamin D deficiency. Adv Exp Med Biol. (2017) 996:169–83. doi: 10.1007/978-3-319-56017-5_14 12. Telcian AG, Zdrenghea MT, Edwards MR, Laza-Stanca V, Mallia P, Johnston SL, et al. Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro. Antiviral Res. (2017) 137:93–101. doi: 10.1016/j.antiviral.2016.11.004 13.Wang Z, Zhang H, Sun X, Ren L. The protective role of vitamin D3 in a murine model of asthma via the suppression of TGF-beta/Smad signaling and activation of the Nrf2/HO-1 pathway. Mol Med Rep. (2016) 14:2389–96. doi: 10.3892/mmr.2016.5563 14. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. (2013) 88:720–55. doi: 10.1016/j.mayocp.2013.05.011 15. Mirzakhani H, Al-Garawi A, Weiss ST, Litonjua AA. Vitamin D and the development of allergic disease: how important is it? Clin Exp Allergy. (2015) 45:114–25. doi: 10.1111/cea.12430 16. Sacheck JM, Van Rompay MI, Chomitz VR, Economos CD, Eliasziw M, Goodman E, et al. Impact of three doses of vitamin D3 on serum 25(OH)D deficiency and insufficiency in at-risk schoolchildren. J Clin Endocrinol Metab. (2017) 102:4496–505. doi: 10.1210/jc.2017-01179 17. Grossman Z, Hadjipanayis A, Stiris T, Del Torso S, Mercier JC, Valiulis A, et al. Vitamin D in European children-statement from the European Academy of Paediatrics (EAP). Eur J Pediatr. (2017) 176:829–31. doi: 10.1007/s00431-017-2903-2 18. DelGiudice NJ, Street N, Torchia RJ, Sawyer SS, Bernard SA, Holick MF. Vitamin D prescribing practices in primary care pediatrics: underpinnings from the health belief model and use of web-based delphi technique for instrument validity. J Pediatr Health Care. (2018) 32:536–47. doi: 10.1016/j.pedhc.2018.03.003 19. Litonjua AA, Carey VJ, Laranjo N, Harshfield BJ, McElrath TF, O'Connor GT, et al. Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the vdaart randomized clinical trial. JAMA. (2016) 315:362–70. doi: 10.1001/jama.2015.18589 20. Braegger C, Campoy C, Colomb V, Decsi T, Domellof M, Fewtrell M, et al. Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr. (2013) 56:692–701. doi: 10.1097/MPG.0b013e31828f3c05 21. Rusinska A, Pludowski P, Walczak M, Borszewska-Kornacka MK, Bossowski A, Chlebna-Sokol D, et al. Vitamin D Supplementation guidelines for general population and groups at risk of vitamin d deficiency in poland-recommendations of the polish society of pediatric endocrinology and diabetes and the expert panel with participation of national specialist consultants and representatives of scientific societies-2018 update. Front Endocrinol. (2018) 9:246. doi: 10.3389/fendo.2018.00246 22. Uysalol M, Uysalol EP, Yilmaz Y, Parlakgul G, Ozden TA, Ertem HV, et al. Serum level of vitamin D and trace elements in children with recurrent wheezing: a cross-sectional study. BMC Pediatr. (2014) 14:270. doi: 10.1186/1471-2431-14-270 23. Eroglu C, Demir F, Erge D, Uysal P, Kirdar S, Yilmaz M, et al. The relation between serum vitamin D levels, viral infections and severity of attacks in children with recurrent wheezing. AllergolImmunopathol. (2019) 47:591–7. doi: 10.1016/j.aller.2019.05.002 24. Dogru M, Seren LP. Serum 25-hydroxyvitamin D levels in children with recurrent wheezing and relation to the phenotypes and frequency of wheezing. Eur Ann Allergy Clin Immunol. (2017) 49:257–62. doi: 10.23822/EurAnnACI.1764-1489.14 25. Pecanha MB, Freitas RB, Moreira TR, Silva LS, Oliveira LL, Cardoso SA. Prevalence of vitamin D deficiency and its relationship with factors associated with recurrent wheezing. J Bras Pneumol. (2019) 45:e20170431. doi: 10.1590/1806-3713/e20170431 27. Vo P, Koppel C, Espinola JA, Mansbach JM, Celedon JC, Hasegawa K, et al. Vitamin D Status at the time of hospitalization for bronchiolitis and its association with disease severity. J Pediatr. (2018) 203:416–22.e1. doi: 10.1016/j.jpeds.2018.07.097 28. Jat KR. Vitamin D deficiency and lower respiratory tract infections in children: a systematic review and meta-analysis of observational studies. Trop Doct. (2017) 47:77–84. doi: 10.1177/0049475516644141 29. Wei Z, Zhang J, Yu X. Maternal vitamin D status and childhood asthma, wheeze, and eczema: A systematic review and meta-analysis. Pediatr Allergy Immunol. (2016) 27:612–9. doi: 10.1111/pai.12593 30. Christensen N, Sondergaard J, Fisker N, Christesen HT. Infant respiratory tract infections or wheeze and maternal vitamin D in pregnancy: a systematic review. Pediatr Infect Dis J. (2017) 36:384–91. doi: 10.1097/INF.0000000000001452 31. Pacheco-Gonzalez RM, Garcia-Marcos L, Morales E. Prenatal vitamin D status and respiratory and allergic outcomes in childhood: a meta-analysis of observational studies. Pediatr Allergy Immunol. (2018) 29:243–53. doi: 10.1111/pai.12876 32. Feng H, Xun P, Pike K, Wills AK, Chawes BL, Bisgaard H, et al. In utero exposure to 25-hydroxyvitamin D and risk of childhood asthma, wheeze, and respiratory tract infections: a meta-analysis of birth cohort studies. J Allergy Clin Immunol. (2017) 139:1508–17. doi: 10.1016/j.jaci.2016.06.065 33.Гарифулина Л. М. Факторы риска развития ожирения и артериальной гипертензии у детей и подростков //Вопросы науки и образования. – 2020. – №. 26 (110). – С. 40-44. 34. Litonjua AA, Carey VJ, Laranjo N, Stubbs BJ, Mirzakhani H, O'Connor GT, et al. Six-year follow-up of a trial of antenatal vitamin D for asthma reduction. N Engl J Med. (2020) 382:525–33. doi: 10.1056/NEJMoa1906137